Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients

Metabolism: Clinical and Experimental

Volumn 49, Issue 1, 2000, Pages 115-121

  Dobs, Adrian S ^a,a,b,c,d   Miller, Sam ^a,b,c,d   Neri, Gilberto ^a,b,c,d   Weiss, Stuart ^a,b,c,d   Tate, Ann C ^a,b,c,d   Shapiro, Deborah R ^a,b,c,d   Musliner, Thomas A ^a,b,c,d   Ayers, Carlos R ^e   Davidson, Michael H ^f   Rutledge, Jack C ^g   Miller, Sam S ^h   Pickering, J Edward ⁱ   Schwartz, Sherwyn L ^j   Toth, Philip D ^k   Wallin, J David ^l   Weiss, Stuart R ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c San Diego Endocrine and Medical Clinic   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

^f RADIANT RESEARCH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h SAM Clinical Research Center   (United States)

ⁱ LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^j Diabetes and Glandular Disease Clinic   (United States)

^k Midwest Institute for Clinical Research   (United States)

^l LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FOLLITROPIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PRAVASTATIN; SEX HORMONE BINDING GLOBULIN; SIMVASTATIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GONAD FUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMEN ANALYSIS; SPERMATOGENESIS; TESTOSTERONE SYNTHESIS;

EID: 0033983170     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)90938-7     Document Type: Article

References (31)

1. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994
2. Shepherd J, Cobbe SM, Ford I, et al: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301-1307, 1995
3. Pedersen TR, Tobert JA: Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease. A reappraisal. Drug Saf 14:11-24, 1996
4. Hubbard SC, Ivatt RJ: Synthesis and processing of asparagine-linked oligosaccharides. Annu Rev Biochem 50:555-583, 1981
5. Matsumoto AM, Bremner WJ: Endocrinology of the hypothalamic-pituitary-testicular axis with particular reference to the hormonal control of spermatogenesis. Baillieres Clin Endocrinol Metab 1:71-87, 1987
6. Dobs AS, Sarma PS, Schteingart D: Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Metabolism 42:1146-1152, 1993
7. Azzarito C, Boiardi L, Zini A, et al: Long-term therapy with high-dose simvastatin does not affect adrenocortical and gonadal hormones in hypercholesterolemic patients. Metabolism 41:148-153, 1992
8. Bernini GP, Argenio GF, Gasperi M, et al: Effects of long-term simvastatin treatment on testicular and adrenal steroidogenesis in hypercholesterolemic patients. J Endocrinol Invest 17:227-233, 1994
9. Travia D, Tosi F, Negri C, et al: Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads. J Clin Endocrinol Metab 80:836-840, 1995
10. Jay RH, Sturley RH, Stirling C, et al: Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolemia. Br J Clin Pharmacol 32:417-422, 1991
11. Prihoda JS, Pappu AS, Smith FE, et al: The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia. J Clin Endocrinol Metab 72:567-574, 1991
12. Purvis K, Tollefsrud A, Rui H, et al: Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia. Eur J Clin Pharmacol 42:61-64, 1992
13. Illingworth DR, Corbin D: The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia. Proc Natl Acad Sci USA 82:6291-6294, 1985
14. Farnsworth WH, Hoeg JM, Maher M, et al: Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin. J Clin Endocrinol Metab 65:546-550, 1987
15. Rossato M, Guarneri G, Lavagnini T, et al: Simvastatin influences testicular steroidogenesis in human. Horm Metab Res 25:503-505, 1993
16. Azzarito C, Boiardi L, Vergoni W, et al: Testicular function in hypercholesterolemic male patients during prolonged simvastatin treatment. Horm Metab Res 28:193-198, 1996
17. Hildebrand RD, Hepperlen TW: Lovastatin and hypospermia. Ann Intern Med 112:549-550, 1990 (letter)
18. Levine RJ, Mathew RM, Chenault CB, et al: Differences in the quality of semen in outdoor workers during summer and winter. N Engl J Med 323:12-16, 1990
19. Smals AGH, Kloppenborg PWC, Benraad TJ: Circannual cycle in plasma testosterone levels in man. J Clin Endocrinol Metab 42:979-982, 1976
20. Griffin JE, Wilson JD: Disorders of the testes and male reproductive tract, in Williams RH, Wilson JD, Foster DW: Williams' Textbook of Endocrinology (ed 7). Philadelphia, PA, Saunders, 1985, pp 259-311
21. Krauss RM, Deckelbaum RJ, Ernst N, et al: Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation 94:1795-1800, 1996
22. Cunningham SK, McKenna TJ: Evaluation of an immunoassay for plasma sex hormone-binding globulin: Comparison with steroid-binding assay under physiological and pathological conditions. Ann Clin Biochem 25:360-366, 1988
23. Friedewald WT, Levy RI, Frederickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
24. Germershausen JI Hunt VM, Bostedor RG, et al: Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo. Biochem Biophys Res Commun 158:667-675, 1989
25. Stein EA, Davidson MH, Dobs AS, et al: Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. Am J Cardiol 82:311-316, 1998
26. Ose L, Kastelein JJP, Scott EA, et al: Efficacy and six-month safety of simvastatin 80 mg/day: Results from the Worldwide Simvastatin Expanded Dose Program (WSEDP). Nutr Metab Cardiovasc Dis 8:143-151, 1998
27. Kjaer K, Hangaard J, Petersen NE, et al: Effect of simvastatin in patients with type I (insulin-dependent) diabetes mellitus and hypercholesterolemia. Acta Endocrinol (Copenh) 126:229-232, 1992
28. Bernini GP, Brogi G, Argenio GF, et al: Effects of long-term pravastatin treatment on spermatogenesis and on adrenal and testicular steroidogenesis in male hypercholesterolemic patients. J Endocrinol Invest 21:310-317, 1998
29. Heller CG, Clermont Y: Spermatogenesis in man: An estimate of its duration. Science 140:84-86, 1963
30. Nanjee MN, Wheeler MJ: Plasma free testosterone - Is an index sufficient? Ann Clin Biochem 22:387-390, 1985
31. Schwanz D, Laplanche A, Jouannet P, et al: Within-subject variability of human semen in regard to sperm count, volume, total number of spermatozoa and length of abstinence. J Reprod Fertil 57:391-395, 1979